audio

Auteur

Sungkanuparph

Œuvres

Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens
Category

Documents

Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens

Manosuthi Weerawat, Mankatitham Wiroj, Lueangniyomkul Aroon, Prasithsirikul Wisit, Tantanathip Preecha, Suntisuklappon Busakorn, Narkksoksung Anongnuch, Nilkamhang Samruay, Sungkanuparph, Sungkanuparph Somnuek

Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens Alternate Text
Category

Documents

Savoirs

Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens

Manosuthi Weerawat, Mankatitham Wiroj, Lueangniyomkul Aroon, Prasithsirikul Wisit, Tantanathip Preecha, Suntisuklappon Busakorn, Narkksoksung Anongnuch, Nilkamhang Samruay, Sungkanuparph, Sungkanuparph Somnuek

Book

8 pages

Flag

English

icon play Lire
icon play Infos
Treatment outcomes and plasma level of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who had NRTI and NNRTI failure
Category

Documents

Treatment outcomes and plasma level of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who had NRTI and NNRTI failure

Manosuthi Weerawat, Kiertiburanakul Sasisopin, Amornnimit Wannarat, Prasithsirikul Wisit, Thongyen Supeda, Nilkamhang Samruay, Ruxrungtham Kiat, Sungkanuparph, Sungkanuparph Somnuek

Treatment outcomes and plasma level of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who had NRTI and NNRTI failure Alternate Text
Category

Documents

Savoirs

Treatment outcomes and plasma level of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who had NRTI and NNRTI failure

Manosuthi Weerawat, Kiertiburanakul Sasisopin, Amornnimit Wannarat, Prasithsirikul Wisit, Thongyen Supeda, Nilkamhang Samruay, Ruxrungtham Kiat, Sungkanuparph, Sungkanuparph Somnuek

Book

5 pages

Flag

English

icon play Lire
icon play Infos
Safety and efficacy of a generic fixed-dose combination of stavudine, lamivudine and nevirapine antiretroviral therapy between HIV-infected patients with baseline CD4 <50 versus CD4 ≥ 50 cells/mm3
Category

Documents

Safety and efficacy of a generic fixed-dose combination of stavudine, lamivudine and nevirapine antiretroviral therapy between HIV-infected patients with baseline CD4 <50 versus CD4 ≥ 50 cells/mm3

Manosuthi Weerawat, Chimsuntorn Sukanya, Likanonsakul Sirirat, Sungkanuparph, Sungkanuparph Somnuek

Safety and efficacy of a generic fixed-dose combination of stavudine, lamivudine and nevirapine antiretroviral therapy between HIV-infected patients with baseline CD4 <50 versus CD4 ≥ 50 cells/mm3 Alternate Text
Category

Documents

Savoirs

Safety and efficacy of a generic fixed-dose combination of stavudine, lamivudine and nevirapine antiretroviral therapy between HIV-infected patients with baseline CD4 <50 versus CD4 ≥ 50 cells/mm3

Manosuthi Weerawat, Chimsuntorn Sukanya, Likanonsakul Sirirat, Sungkanuparph, Sungkanuparph Somnuek

Book

8 pages

Flag

English

icon play Lire
icon play Infos
  • Univers Univers
  • Ebooks Ebooks
  • Livres audio Livres audio
  • Presse Presse
  • Podcasts Podcasts
  • BD BD
  • Documents Documents
expand_more
Alternate Text